Yes, many patients switch from phentermine to a GLP-1 medication like Wegovy for long-term weight management
Glutathione-S-transferases can also display a GSH-dependent thiol-transferase activity that generates disulfide bridges, which can link the thiols of the cysteinyl residue of two molecules of GSH, yielding GSSG ( Glutathione-S-transferases can also have GSH-dependent peroxidase (GPOX) and dehydroascorbate reductase (GDHAR) activities ( In addition, GSTs can also have a non-catalytic ligandin activity that binds non-substrate ligands ( Glutathione-S-transferases are commonly divided in three different families: (i) cytosolic GSTs, (ii) mitochondrial GSTs, and (iii) microsomal (membranous) GSTs designated as MAPEGs (membrane-associated protein involved in ecosanod and glutathione metabolism) (Wiktelius and Stenberg, 2007
in some cases, skin removal surgeries can be considered and even covered by insurance if deemed medically necessary (e.g., for rashes) [utswmed.org]
Initial phase (Weeks 0-8): Weight loss typically begins within the first few weeks of treatment, though the rate is initially modest due to the low starting dose
This is a class effect, meaning it applies to all GLP-1 medications to varying degrees, not just one specific drug